Inactive Instrument

Insiders Innovate Biopharmaceuticals Inc Nasdaq

Equities

US61174L5012

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

9 Meters Biopharma Names Bethany Sensenig Interim Chief Executive; Shares Fall	30/23/30	MT
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President	30/23/30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer	30/23/30	CI
9 Meters Biopharma, Inc. Appoints Bethany Sensenig as Interim CEO	30/23/30	CI
9 Meters Biopharma Names Bethany Sensenig its new Chief Financial Officer	18/22/18	MT
9 Meters Biopharma, Inc. Announces Executive Appointment	03/22/03	CI
9 Meters Biopharma Inc. Appoints Samantha Ventimiglia to Board of Directors	04/21/04	CI
Insider Trends: Selling By Insiders Lingers at 9 Meters Biopharma	26/21/26	MT
9 Meters Biopharma, Inc. Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome	17/21/17	CI
Insider Trends: Insider Buying Added to with Purchase of 9 Meters Biopharma Shares	07/21/07	MT
9 Meters Biopharma Inc Appoints Michael Rice as Board of Director	01/21/01	CI
9 Meters Biopharma, Inc. Announces the Resignation of Nissim Darvish as Director	16/21/16	CI
Insider Trends: 9 Meters Biopharma Insider 90-Day Buying Trend Prolonged with Purchase	18/20/18	MT
9 Meters Biopharma, Inc. Announces the Formation of Its Scientific Advisory Board	31/20/31	CI
9 Meters Biopharma, Inc. Appoints Michael T. Constantino as A Member of the Board and Chair of the Audit Committee	07/20/07	CI
Innovate Biopharma Wt will Change its Name to 9 Meters Biopharma, Inc	11/20/11	CI
9 Meters Biopharma, Inc. Announces Board and Management Changes	05/20/05	CI
Innovate Biopharmaceuticals, Inc. will Change its Name to 9 Meters Biopharma, Inc	04/20/04	CI
Innovate Biopharmaceuticals, Inc. Announces Jay P. Madan, M.S., Will No Longer Serve as the Interim Principal Financial Officer and Interim Principal Accounting Officer	28/19/28	CI
Innovate Biopharmaceuticals, Inc. Announces Executive Changes	20/19/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Innovate Biopharmaceuticals Inc Nasdaq

Equities

US61174L5012

Insiders

Filters